Free Trial

State Street Corp Increases Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Definitive Healthcare logo with Medical background

State Street Corp raised its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 29.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,399,729 shares of the company's stock after purchasing an additional 317,952 shares during the quarter. State Street Corp owned 1.21% of Definitive Healthcare worth $6,257,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company boosted its stake in shares of Definitive Healthcare by 17.0% in the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company's stock valued at $125,000 after purchasing an additional 3,332 shares during the period. Principal Financial Group Inc. lifted its holdings in Definitive Healthcare by 10.8% during the 2nd quarter. Principal Financial Group Inc. now owns 39,856 shares of the company's stock worth $218,000 after buying an additional 3,874 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Definitive Healthcare by 31.4% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company's stock valued at $116,000 after buying an additional 5,083 shares during the period. Glenmede Trust Co. NA grew its stake in shares of Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after acquiring an additional 5,362 shares in the last quarter. Finally, Point72 DIFC Ltd increased its position in shares of Definitive Healthcare by 759.9% during the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after acquiring an additional 8,215 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

DH has been the subject of a number of recent research reports. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a report on Friday, November 8th. BTIG Research assumed coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They issued a "buy" rating and a $7.00 price objective for the company. Finally, Stephens initiated coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an "equal weight" rating and a $5.00 price objective for the company. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $5.72.

Check Out Our Latest Report on Definitive Healthcare

Insider Activity

In related news, insider William Moschella sold 45,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. This trade represents a 9.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 14.84% of the company's stock.

Definitive Healthcare Stock Down 0.5 %

DH traded down $0.02 on Friday, reaching $4.23. The company's stock had a trading volume of 428,518 shares, compared to its average volume of 713,971. The company has a market capitalization of $488.66 million, a price-to-earnings ratio of -1.36, a P/E/G ratio of 3.29 and a beta of 1.40. Definitive Healthcare Corp. has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The stock has a 50 day moving average of $4.38 and a two-hundred day moving average of $4.62.

Definitive Healthcare Company Profile

(Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Stories

Institutional Ownership by Quarter for Definitive Healthcare (NASDAQ:DH)

Should You Invest $1,000 in Definitive Healthcare Right Now?

Before you consider Definitive Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.

While Definitive Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines